The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AusPAR: Denosumab
Australian Public Assessment Report
Device/Product Name
Xgeva
Active ingredients
Denosumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2010-02051-3-4
Submission Type
New indication, New strength